Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Healthequity (HQY) Long-Term Debt Repayments (2020 - 2026)

Healthequity has reported Long-Term Debt Repayments over the past 8 years, most recently at $25.0 million for Q1 2026.

  • Quarterly results put Long-Term Debt Repayments at $25.0 million for Q1 2026, changed 0.0% from a year ago — trailing twelve months through Jan 2026 was $611.9 million (up 8.9% YoY), and the annual figure for FY2026 was $100.0 million, down 82.2%.
  • Long-Term Debt Repayments for Q1 2026 was $25.0 million at Healthequity, roughly flat from $25.0 million in the prior quarter.
  • Over the last five years, Long-Term Debt Repayments for HQY hit a ceiling of $536.9 million in Q4 2024 and a floor of $2.2 million in Q2 2022.
  • Median Long-Term Debt Repayments over the past 5 years was $25.0 million (2025), compared with a mean of $75.0 million.
  • Biggest five-year swings in Long-Term Debt Repayments: crashed 99.78% in 2022 and later skyrocketed 2386.28% in 2023.
  • Healthequity's Long-Term Debt Repayments stood at $2.2 million in 2022, then skyrocketed by 2386.28% to $54.4 million in 2023, then skyrocketed by 887.36% to $536.9 million in 2024, then crashed by 95.34% to $25.0 million in 2025, then changed by 0.0% to $25.0 million in 2026.
  • The last three reported values for Long-Term Debt Repayments were $25.0 million (Q1 2026), $25.0 million (Q4 2025), and $25.0 million (Q1 2025) per Business Quant data.